信达生物获摩根大通增持约40.86万股 每股作价约84.94港元

Group 1 - Morgan Stanley increased its stake in Innovent Biologics (01801) by 408,630 shares at a price of HKD 84.9352 per share, totaling approximately HKD 34.7071 million [1] - After the increase, Morgan Stanley's total shareholding in Innovent Biologics reached approximately 86,908,100 shares, representing a 5% ownership stake [1]